Julian Viggars: Investments against COVID-19 ^{UK Investors}

Julian joined Mercia Technologies in 2003 and was previously Head of Technology Investments at Mercia, before being appointed as Chief Investment Officer in April 2018. Julian has over 20 years' venture capital experience and oversees all of the investment activity of the Group across venture, growth equity and debt, in addition to managing the Investment Team. He is also a Fund Manager for NPIF - Mercia Equity Finance, the RisingStars Growth Funds, and the Finance Yorkshire Seedcorn Fund, which include successful listed businesses Blue Prism, Xeros, and Optibiotix PLC. In addition, Julian has been a non-executive director of Xeros PLC since 2009, is a member of the BVCA’s membership committee, and Investment Director at Enterprise Ventures. Also, he was previously a Director of BioProjects International plc, an AIM-listed early stage technology fund, and an Associate Partner with accountancy firm NCL Smith & Williamson in London. Julian leads the EV Tech investment team in Enterprise Ventures, and is responsible for EV’s technology investment activities. He has particular expertise in the healthcare and IT sectors.

Invested in Blue Prism.

Connections

Blue Prism: against COVID-19

Funding Status: N/A

Headquarters: United Kingdom

Founded Date: N/A

Investor Type: N/A

Investment Stage: N/A

Technology: COVID UK Funding&Support

Employee Number: N/A

Number Of Exists: N/A

Industry: COVID UK Non-governmental Bodies

Julian Viggars: Investments against COVID-19 UK Investors

Connections

Julian Viggars: Investments against COVID-19 ^{UK Investors}